You just read:

Data from iPrEx Open-Label Extension (OLE) Demonstrate High Interest in PrEP, Longer-term Evidence of Safety and Efficacy, and No Sign of Increased Risk Behavior Among PrEP Users

News provided by

San Francisco AIDS Foundation

Jul 22, 2014, 02:30 ET